Table 7.
Group |
Samplev (n) |
Fibrosis Phase |
Fibrotic area within 1.5 mm2(mm2) |
||||
---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | |||
Nomral |
7 |
7 |
0 |
0 |
0 |
0 |
0 |
Model |
7 |
0 |
0 |
1 |
4 |
2 |
0.52 ± 0.23 △△ |
Silymarin |
7 |
0 |
0 |
6 |
1 |
0 |
0.27 ± 0.10** |
Berberine |
7 |
0 |
0 |
5 |
2 |
0 |
0.34 ± 0.18* |
CRAE |
7 |
0 |
2 |
4 |
1 |
0 |
0.28 ± 0.14** |
Bear Bile |
7 |
0 |
2 |
4 |
1 |
0 |
0.26 ± 0.12** |
TUDCA | 7 | 1 | 6 | 0 | 0 | 0 | 0.14 ± 0.049** |
△p < 0.05 when compared with normal group; △△p < 0.01 when compared with normal group; *p < 0.05 when compared with model group; **p < 0.01 when compared with model group.